These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24135397)

  • 1. Introduction: recent advances in the understanding and management of multiple myeloma.
    Jakubowiak AJ
    Semin Oncol; 2013 Oct; 40(5):535-6. PubMed ID: 24135397
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmacytoma of the skull.
    Gozzetti A; Cerase A; Defina M; Bocchia M
    Eur J Haematol; 2012 Apr; 88(4):369. PubMed ID: 22082085
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma: epidemiology and therapeutic options.
    Tuscano JM
    Manag Care; 2008 Jul; 17(7 Suppl 6):9-15. PubMed ID: 19093334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of myeloma--state of the art.
    Harousseau JL
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S1-2. PubMed ID: 20472182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
    Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
    Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the management of myeloma.
    Hughes M; Soutar RL
    Scott Med J; 2005 May; 50(2):47-50. PubMed ID: 15977512
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.
    Tan D; Lee JH; Chen W; Shimizu K; Hou J; Suzuki K; Nawarawong W; Huang SY; Sang Chim C; Kim K; Kumar L; Malhotra P; Chng WJ; Durie B;
    Leuk Lymphoma; 2018 Oct; 59(10):2305-2317. PubMed ID: 29390932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
    Mangiacavalli S; Pica G; Varettoni M; Lazzarino M; Corso A
    Eur J Haematol; 2009 Mar; 82(3):240-1. PubMed ID: 19018860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple melanoma-progress in understanding of molecular mechanism and improvement in treatment outcome with introduction of new drugs for multiple myeloma].
    Hanamura I; Iida S
    Gan To Kagaku Ryoho; 2010 May; 37(5):816-21. PubMed ID: 20524255
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains.
    Mead GP; Carr-Smith HD; Drayson MT; Bradwell AR
    Clin Lab; 2003; 49(1-2):25-7. PubMed ID: 12593472
    [No Abstract]   [Full Text] [Related]  

  • 11. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
    Nucci M; Anaissie E
    Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.
    Amodio N; Di Martino MT; Neri A; Tagliaferri P; Tassone P
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S125-37. PubMed ID: 23692413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in treating multiple myeloma. Thanks to a host of effective new therapies, patients are enjoying years in remission from this malignant blood cancer.
    Harv Womens Health Watch; 2010 Jul; 17(11):4-6. PubMed ID: 20684078
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.
    Allegra A; Sant'antonio E; Penna G; Alonci A; D'Angelo A; Russo S; Cannavò A; Gerace D; Musolino C
    Eur J Haematol; 2011 Feb; 86(2):93-110. PubMed ID: 21114539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agents and the paradigm of continuous treatment in multiple myeloma.
    Palumbo A
    Leuk Res; 2012 Nov; 36 Suppl 1():S1-2. PubMed ID: 23176718
    [No Abstract]   [Full Text] [Related]  

  • 16. Lenalidomide in multiple myeloma: current experimental and clinical data.
    Cives M; Milano A; Dammacco F; Silvestris F
    Eur J Haematol; 2012 Apr; 88(4):279-91. PubMed ID: 22085323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New horizons in multiple myeloma therapy.
    Santos ES; Kharfan-Dabaja MA
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1483-501. PubMed ID: 17069532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatment strategy of multiple myeloma for cure].
    Murakami H; Handa H
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):417-23. PubMed ID: 16612147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma].
    Murakami H; Saitoh T; Kasamatsu T
    Gan To Kagaku Ryoho; 2016 May; 43(5):539-44. PubMed ID: 27344682
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current perspectives in the treatment of multiple myeloma - news and views].
    Knop S
    Dtsch Med Wochenschr; 2012 Mar; 137(13):636-9. PubMed ID: 22434170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.